Gary V. Doern

17.2k citations

237 papers · 13.6k indexed · h-index 62

Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance 18
Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 49
Clinical Biochemistry top 0.02%
- Bacterial Identification and Susceptibility Testing 69
Microbiology top 0.1%
- Bacterial Infections and Vaccines 41
Infectious Diseases top 0.1%
- Antimicrobial Resistance in Staphylococcus 48
Epidemiology
- Pneumonia and Respiratory Infections 83
Pharmacology
- Antibiotics Pharmacokinetics and Efficacy 48
Public Health, Environmental and Occupational Health
- Streptococcal Infections and Treatments 31

Co-authors: Michael A. Pfaller Angela B. Brueggemann Ronald N. Jones Daniel J. Diekema Susan E. Beekmann Kari C. Kugler Kristopher P. Heilmann Sandra S. Richter
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Clinical Biochemistry
Journals: Journal of Clinical Microbiology (68 papers)Diagnostic Microbiology and Infectious Disease (46 papers)Antimicrobial Agents and Chemotherapy (29 papers)
Partner nations: United States Brazil United Kingdom

In The Last Decade

Gary V. Doern

235 papers receiving 12.7k citations

Peers

Countries citing papers authored by Gary V. Doern

Since Specialization

Citations

This map shows the geographic impact of Gary V. Doern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary V. Doern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary V. Doern more than expected).

Fields of papers citing papers by Gary V. Doern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary V. Doern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary V. Doern. The network helps show where Gary V. Doern may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary V. Doern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary V. Doern Line = papers co-authored together Gary V. Doern links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States Antimicrobial Agents and Chemotherapy ·Sandra S. Richter,Daniel J. Diekema,Kristopher P. Heilmann,Cassie L. Dohrn,Fathollah Riahi,Gary V. Doern	2014	129
2	Antibiotic Resistance in Sputum Isolates ofStreptococcus pneumoniaein Chronic Obstructive Pulmonary Disease is Related to Antibiotic Exposure COPD Journal of Chronic Obstructive Pulmonary Disease ·Himanshu Desai,Sandra S. Richter,Gary V. Doern,Kris P. Heilmann,Cassie L. Dohrn,M Sarala,Aimee L. Brauer,Timothy F. Murphy,Sanjay Sethi	2010	20
3	Accuracy of Phenotypic Methods for Identification of Streptococcus pneumoniae Isolates Included in Surveillance Programs Journal of Clinical Microbiology ·Sandra S. Richter,Kristopher P. Heilmann,Cassie L. Dohrn,Fathollah Riahi,Susan E. Beekmann,Gary V. Doern	2008	44
4	Timing of Specimen Collection for Blood Cultures from Febrile Patients with Bacteremia Journal of Clinical Microbiology ·Stefan Riedel,Paul Bourbeau,N. I︠a︡. Marr,金田忠裕,Karen C. Carroll,Paul D. Stamper,W. Michael Dunne,More Suhas,بندر عویض الجعید,Kristin Fiebelkorn,David L. Sewell,Sandra S. Richter,Susan E. Beekmann,Gary V. Doern	2008	78
5	Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 Journal of Clinical Microbiology ·Shawn R. Lockhart,Murray A. Abramson,Susan E. Beekmann,G. Gallagher,Stefan Riedel,Daniel J. Diekema,John P. Quinn,Gary V. Doern	2007	309
6	Antimicrobial Resistance with Bacterial Causes of Community-Acquired Respiratory Tract Infections in the United States PubMed ·Gary V. Doern	2005	2
7	Fluoroquinolone Resistance inStreptococcus pyogenes Clinical Infectious Diseases ·Sandra S. Richter,Daniel J. Diekema,Kris P. Heilmann,Laurel S. Almer,Virginia D. Shortridge,Rodney Zeitler,Robert K. Flamm,Gary V. Doern	2003	33
8	Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere American Journal of Obstetrics and Gynecology ·Janet I. Andrews,Daniel J. Diekema,Stephen K. Hunter,Paul R. Rhomberg,Michael A. Pfaller,Ronald N. Jones,Gary V. Doern	2000	87
9	Detection of Selected Fastidious Bacteria Clinical Infectious Diseases ·Gary V. Doern	2000	58
10	Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98 Emerging infectious diseases ·Gary V. Doern,Angela B. Brueggemann,Holly K. Huynh,大文高,Paul R. Rhomberg	1999	165
11	Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) Diagnostic Microbiology and Infectious Disease ·Gary V. Doern,Ronald N. Jones,Michael A. Pfaller,Kari C. Kugler,Mondell L. Beach	1999	120
12	Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program Diagnostic Microbiology and Infectious Disease ·Michael A. Pfaller,Ronald N. Jones,Gary V. Doern,Hélio S. Sader,Kari C. Kugler,Mondell L. Beach	1999	199
13	Multicenter Evaluation of the Antimicrobial Activity for Six Broad-Spectrum β-Lactams in Venezuela Using the Etest Method Diagnostic Microbiology and Infectious Disease ·Michael A. Pfaller,Ronald N. Jones,Gary V. Doern	1998	35
14	Partial Liquid Ventilation with Perfluorocarbon in the Treatment of Rats with Lethal Pneumococcal Pneumonia Anesthesiology ·Eric W. Dickson,Stephen O. Heard,yiping wang,Armando E. Fraire,Angela B. Brueggemann,Gary V. Doern	1998	23
15	Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program Clinical Infectious Diseases ·Gary V. Doern,Michael A. Pfaller,Kari C. Kugler,Cho Nam-Ho,Ronald N. Jones	1998	328
16	Resistance among problem respiratory pathogens in pediatrics The Pediatric Infectious Disease Journal ·Gary V. Doern	1995	23
17	Selective media for detecting gastrointestinal carriage of vancomycin-resistant enterococci Diagnostic Microbiology and Infectious Disease ·M. D. Cowan,Gary V. Doern	1995	11
18	Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium Diagnostic Microbiology and Infectious Disease ·Ronald N. Jones,Gary V. Doern,E. Gerlach,Janet Hindler,M E Erwin	1994	9
19	In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae Diagnostic Microbiology and Infectious Disease ·Gary V. Doern,Ade Johan	1992	6
20	Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium Diagnostic Microbiology and Infectious Disease ·Gary V. Doern,E. Gerlach,James H. Jorgensen,Patrick R. Murray,Clyde Thornsberry,ZHANGYun	1991	17

About Gary V. Doern

Gary V. Doern is a scholar working on Clinical Biochemistry, Molecular Medicine, Applied Microbiology and Biotechnology, Microbiology and Epidemiology, having authored 237 papers that have together received 13.6k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (83 papers), Bacterial Identification and Susceptibility Testing (69 papers), Antibiotic Resistance in Bacteria (49 papers), Antibiotics Pharmacokinetics and Efficacy (48 papers), Antimicrobial Resistance in Staphylococcus (48 papers), Bacterial Infections and Vaccines (41 papers), Streptococcal Infections and Treatments (31 papers) and Antibiotic Use and Resistance (18 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.4k citations), Molecular Medicine (3.2k citations), Clinical Biochemistry (3.1k citations), Microbiology (1.8k citations) and Infectious Diseases (4.4k citations). Gary V. Doern has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Michael A. Pfaller, Angela B. Brueggemann, Ronald N. Jones, Daniel J. Diekema, Susan E. Beekmann, Kari C. Kugler, Kristopher P. Heilmann, Sandra S. Richter, Stacy L. Coffman and S. A. Messer. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases and European Journal of Clinical Microbiology & Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact